… We present the results of a phase II clinical trial that followed a previous phase I clinical trial
… a dose of autologous 100 million BM-MSCs, and with a clinical improvement that remained …

… study we conducted a phase I/II randomized controlled trial of autologous bone marrow-derived
MSC … This study was initiated from the randomised Phase II from the Korean Neurologist, …

… This meta-analysis summarizes the evidence available from randomized controlled trial (RCTs)
that study bone marrow–derived cell therapy in critical limb ischemia patients. It …

… We report a comparison of time to recovery, side effects, and … Blood and Marrow Transplant
Clinical Trials Network phase III … Transfusion of stored autologous blood was in accordance …

… Transplantation of autologous bone marrow – derived mononuclear … Several clinical studies
have shown that a variety of … -T, an autologous expanded multicellular mixture from bone …

… Hematopoietic stem cells intended for autologous transplantation are usually … -blinded,
randomized study comparing these cryoprotectant solutions for patients undergoing autologous …

… One meta-analysis examined 18 clinical trials on knee OA, which included 10 single-arm
prospective studies, four quasi-experimental studies and four randomized controlled trials (…

… autologous bone marrow in chronic myocardial infarction using a helical needle catheter:
1-year follow-up in an open-label, nonrandomized, single-center pilot study (the TABMMI study)…

… , phase I clinical trial to determine the safety and feasibility of intravenous (IV)
administration of autologous bone marrow … randomized controlled trials. Stem Cells 2019;37:1481–1491 …

… Our aim was to investigate the effect of autologous bone marrow-derived stem cell (BMSC) …
Ours was an academia-initiated exploratory phase II study. There was no external sponsor …